SATURDAY, JUNE 24, 2017

Vaxart announces Phase I results of tablet influenza vaccine

H1N1 Read More »

Kitasato Daiichi Sankyo Vaccine submits NDA in Japan for influenza vaccine

Kitasato Daiichi Sankyo Vaccine Co., Ltd., the domestic subsidiary of Daiichi Sankyo Company, Ltd., announced its submission on Wednesday of a new drug application for its cell culture-based pandemic influenza vaccine. Read More »

Study shows flu shot prevented 13 million illnesses

Flu vaccine Read More »

MSF vaccinates 30,000 children against measles

Médecins Sans Frontières concluded a measles vaccination campaign in Sudan on May 26 that vaccinated more than 300,000 children. Read More »

Investor sues Dynavax

Shareholder rights attorneys at Robbins Arroyo, LLP, a securities litigation firm, announced on Thursday that a purchaser of securities from Dynavax Technologies Corp. filed a complaint against the vaccine developer. Read More »

FDA approves first genotyping test for HCV patients

Hepatitis Read More »

Herpes vaccine moves to Phase I clinical trial

Allied Healthcare Group announced on Wednesday that its Herpes Simplex Virus vaccine received ethical approval and is headed to a Phase I clinical trial. Read More »

BIO commends Congress on passing excise tax on influenza vaccine

The Biotechnology Industry Organization recently applauded Sens. Max Baucus (D-Mont.) and Orrin Hatch (R-Utah) and Representatives Jim Gerlach (R-Pa.) and Richard Neal (D-Mass.) for passing H.R. 475, which would add the four-strain influenza vaccine to the excise tax. Read More »

Antibacterial compound from HIV may fight drug-resistant bacteria

HIV Read More »

Hospital reduces C. difficile incidence through rigorous interventions

Clostridium difficile Read More »

Researchers find new details about H7N9 in China

H7N9 Virus Read More »

FDA approves new bacterial pneumonia antibiotic

The U.S. Food and Drug Administration announced on Friday that it approved the antibiotic Vibativ, which treats hospital-acquired and ventilator-associated bacterial pneumonia. Read More »

ACIP recommends Flublok flu vaccine for adults with egg allergies

Influenza Read More »

Sabin Vaccine Institute launches association of immunization managers

Sabin Vaccine Institute, a non-profit organization dedicated to reducing suffering caused by vaccine-preventable and tropical diseases, announced the launch on Monday of the International Association of Immunization Managers. Read More »

Study shows no risk of Guillain-Barre syndrome after vaccination

A study released by Kaiser Permanente on Monday showed that patients are not at an increased risk of Guillain-Barré syndrome in the six-week period after they receive a vaccination. Read More »

FIND announces new CEO

The Board of Directors of the Foundation for Innovative New Diagnostics announced on June 21 that Dr. Catharina Boehme is assuming the position of Chief Executive Officer of FIND. Read More »

AmVac receives two grants from EU for vaccine development

AmVac, a Switzerland-based biopharmaceutical company, announced the approval on Tuesday of two European Union grant applications for the development of flu and leishmaniasis vaccines. Read More »

Gates Foundation and Rotary extend fundraising agreement to conquer polio

The Bill & Melinda Gates Foundation and Rotary International announced an extension on Tuesday of an existing fundraising partnership that could result in $525 million in new money for the eradication of polio. Read More »

BIO praises senators for updating excise tax on vaccines

The Biotechnology Industry Organization praised Sens. Max Baucus (D-Mont.) and Orrin Hatch (R-Utah) and Representatives Jim Gerlach (R-Pa.) and Richard Neal (D-Mass.) on Tuesday for their role in passing H.R. 475, which updates the excise tax on vaccines. Read More »

Researchers release new H7N9 risk assessment

H7N9 Virus Read More »